Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCC38 | AS605240 | 1 | 72 | 0.32 | 3883.8 | 4340.3 | 1295.5 | -0.495 | 0.877 | 0.895 | 1.744 | HCC38 AS605240 0 1 72 |
| HCC38 | AS605240 | 1 | 72 | 0.1 | 3986.0 | 4340.3 | 1295.5 | -1.0 | 0.905 | 0.918 | 1.744 | HCC38 AS605240 0 1 72 |
| HCC38 | AS605240 | 1 | 72 | 0.032 | 4330.3 | 4340.3 | 1295.5 | -1.49 | 0.997 | 0.998 | 1.744 | HCC38 AS605240 0 1 72 |
| HCC38 | AS605240 | 1 | 72 | 0.01 | 4351.3 | 4340.3 | 1295.5 | -2.0 | 1.000 | 1.000 | 1.744 | HCC38 AS605240 0 1 72 |
| HCC38 | AS605240 | 1 | 72 | 0.0032 | 4276.0 | 4340.3 | 1295.5 | -2.49 | 0.983 | 0.985 | 1.744 | HCC38 AS605240 0 1 72 |
| HCC38 | AS605240 | 1 | 72 | 0.001 | 4413.5 | 4340.3 | 1295.5 | -3.0 | 1.020 | 1.020 | 1.744 | HCC38 AS605240 0 1 72 |